Pharma Mar SA
MAD:PHM

Watchlist Manager

Pharma Mar SA

MAD:PHM

Watchlist

Dividends

Price: 79.85 EUR -1.11% Market Closed

Market Cap: 1.4B EUR

Have any thoughts about
Pharma Mar SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 79.85 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

PHM Alert

Pharma Mar SA

79.85

-0.90 (-1.11%)

52 Week Range	26.24 80.75
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Pharma Mar SA

What unique competitive advantages
does Pharma Mar SA hold over its rivals?

What risks and challenges
does Pharma Mar SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Pharma Mar SA.

What unique competitive advantages
does Pharma Mar SA hold over its rivals?

What risks and challenges
does Pharma Mar SA face in the near future?

Summarize the latest earnings call
of Pharma Mar SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pharma Mar SA.

Provide P/S
for Pharma Mar SA.

Provide P/E
for Pharma Mar SA.

Provide P/OCF
for Pharma Mar SA.

Provide P/FCFE
for Pharma Mar SA.

Provide P/B
for Pharma Mar SA.

Provide EV/S
for Pharma Mar SA.

Provide EV/GP
for Pharma Mar SA.

Provide EV/EBITDA
for Pharma Mar SA.

Provide EV/EBIT
for Pharma Mar SA.

Provide EV/OCF
for Pharma Mar SA.

Provide EV/FCFF
for Pharma Mar SA.

Provide EV/IC
for Pharma Mar SA.

Show me price targets
for Pharma Mar SA made by professional analysts.

What are the Revenue projections
for Pharma Mar SA?

How accurate were the past Revenue estimates
for Pharma Mar SA?

What are the Net Income projections
for Pharma Mar SA?

How accurate were the past Net Income estimates
for Pharma Mar SA?

What are the EPS projections
for Pharma Mar SA?

How accurate were the past EPS estimates
for Pharma Mar SA?

What are the EBIT projections
for Pharma Mar SA?

How accurate were the past EBIT estimates
for Pharma Mar SA?

Compare the revenue forecasts
for Pharma Mar SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pharma Mar SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pharma Mar SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pharma Mar SA compared to its peers.

Compare the P/E ratios
of Pharma Mar SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Pharma Mar SA with its peers.

Analyze the financial leverage
of Pharma Mar SA compared to its main competitors.

Show all profitability ratios
for Pharma Mar SA.

Provide ROE
for Pharma Mar SA.

Provide ROA
for Pharma Mar SA.

Provide ROIC
for Pharma Mar SA.

Provide ROCE
for Pharma Mar SA.

Provide Gross Margin
for Pharma Mar SA.

Provide Operating Margin
for Pharma Mar SA.

Provide Net Margin
for Pharma Mar SA.

Provide FCF Margin
for Pharma Mar SA.

Show all solvency ratios
for Pharma Mar SA.

Provide D/E Ratio
for Pharma Mar SA.

Provide D/A Ratio
for Pharma Mar SA.

Provide Interest Coverage Ratio
for Pharma Mar SA.

Provide Altman Z-Score Ratio
for Pharma Mar SA.

Provide Quick Ratio
for Pharma Mar SA.

Provide Current Ratio
for Pharma Mar SA.

Provide Cash Ratio
for Pharma Mar SA.

What is the historical Revenue growth
over the last 5 years for Pharma Mar SA?

What is the historical Net Income growth
over the last 5 years for Pharma Mar SA?

What is the current Free Cash Flow
of Pharma Mar SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pharma Mar SA.

PHM

Income Statement

EPS (Diluted)

Pharma Mar SA
EPS (Diluted)

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Pharma Mar SA
EPS (Diluted) Peer Comparison

Comparables:

GRF

ORY

BST

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

	EPS (Diluted)	CAGR 3Y	CAGR 5Y	CAGR 10Y
Pharma Mar SA MAD:PHM	EPS (Diluted) €0	CAGR 3-Years N/A	CAGR 5-Years 42%	CAGR 10-Years N/A
Grifols SA MAD:GRF	EPS (Diluted) €0	CAGR 3-Years -54%	CAGR 5-Years -36%	CAGR 10-Years N/A
Oryzon Genomics SA MAD:ORY	EPS (Diluted) €0	CAGR 3-Years 0%	CAGR 5-Years -15%	CAGR 10-Years N/A
Biotechnology Assets SA MAD:BST	EPS (Diluted) €0	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

What is Pharma Mar SA's EPS (Diluted)?

EPS (Diluted)
-0.1 EUR

Based on the financial report for Jun 30, 2024, Pharma Mar SA's EPS (Diluted) amounts to -0.1 EUR.

Pharma Mar SA
MAD:PHM

Pharma Mar SA
EPS (Diluted)

Pharma Mar SA
EPS (Diluted) Peer Comparison

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

See Also

What is Pharma Mar SA's EPS (Diluted)?

EPS (Diluted)
-0.1 EUR

What is Pharma Mar SA's EPS (Diluted) growth rate?

EPS (Diluted) CAGR 5Y
42%

Company

Help

Tools

Stocks

Pharma Mar SA MAD:PHM

Pharma Mar SA EPS (Diluted)

Pharma Mar SA EPS (Diluted) Peer Comparison

Competitive EPS (Diluted) Analysis Latest Figures & CAGR of Competitors

See Also

What is Pharma Mar SA's EPS (Diluted)? EPS (Diluted) -0.1 EUR

What is Pharma Mar SA's EPS (Diluted) growth rate? EPS (Diluted) CAGR 5Y 42%

Company

Help

Tools

Stocks

Pharma Mar SA
MAD:PHM

Pharma Mar SA
EPS (Diluted)

Pharma Mar SA
EPS (Diluted) Peer Comparison

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

What is Pharma Mar SA's EPS (Diluted)?

EPS (Diluted)
-0.1 EUR

What is Pharma Mar SA's EPS (Diluted) growth rate?

EPS (Diluted) CAGR 5Y
42%